Screener
UroGen Pharma URGN Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $72.46M+199% | $50.96M+152% | $37.84M+54.0% | $27.48M+9.0% | $24.22M+10.8% |
FAQ
- What is UroGen Pharma's revenue?
- UroGen Pharma (URGN) generated $188.7M in revenue over the trailing twelve months, up 100.3% year over year.
- Is UroGen Pharma profitable?
- UroGen Pharma is not currently profitable: it reported a net loss of $97.6M over the trailing twelve months, a -51.7% net margin.
- What are UroGen Pharma's profit margins?
- Gross margin is 89.7% and operating margin is -329.7%, with a -51.7% net margin.
- Where does UroGen Pharma's income statement data come from?
- Every line is extracted from UroGen Pharma's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
